Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 6.46
+0.06 (0.94%)
At close: Mar 10, 2026
SHE:300039 Revenue
Shanghai Kaibao Pharmaceutical CO.,Ltd had revenue of 214.37M CNY in the quarter ending September 30, 2025, a decrease of -26.61%. This brings the company's revenue in the last twelve months to 1.17B, down -24.97% year-over-year. In the year 2024, Shanghai Kaibao Pharmaceutical CO.,Ltd had annual revenue of 1.47B, down -7.57%.
Revenue (ttm)
1.17B
Revenue Growth
-24.97%
P/S Ratio
5.77
Revenue / Employee
956.01K
Employees
1,225
Market Cap
6.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.47B | -120.73M | -7.57% |
| Dec 31, 2023 | 1.59B | 475.20M | 42.47% |
| Jan 1, 2023 | 1.12B | 18.27M | 1.66% |
| Jan 1, 2022 | 1.10B | 192.57M | 21.21% |
| Dec 31, 2020 | 908.01M | -511.02M | -36.01% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Sun-Novo Pharmaceutical Research | 1.22B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Guizhou Bailing Group Pharmaceutical | 3.15B |
| ChengDa Pharmaceuticals | 374.46M |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Beijing SL Pharmaceutical | 578.61M |
| Jinghua Pharmaceutical Group | 1.45B |
| Heilongjiang ZBD Pharmaceutical | 1.59B |